Article Type

1 - 15 of 338 Results       Clear All

New Study from SF Gladstone Institutes Sheds Light on Cause of Brain Fog Due to COVID-19

Gladstone in the News September 26, 2024

New Study from SF Gladstone Institutes Sheds Light on Cause of Brain Fog Due to COVID-19

ABC7 News—The most commonly reported symptom of long COVID is brain fog, which interferes with your ability to think clearly, remember things, and focus on a task. Senior Investigator Katerina Akassoglou explains the findings from her study that shed new light on what causes brain fog and the many other brain-related symptoms of long COVID and COVID-19.

Gladstone Experts COVID-19 Akassoglou Lab

Guest Opinion: How Should We Pay for New Breakthrough Cures?

Gladstone in the News September 16, 2024

Guest Opinion: How Should We Pay for New Breakthrough Cures?

San Francisco Business Times—The world’s first CRISPR-based drug that alters the genetic code is on the market. Thousands of other therapies using gene editing or stem cell technologies are in the works and offer potential cures. But how will society pay for these life-saving drugs? In this opinion piece, Gladstone President Deepak Srivastava shares his views on a new world of medical possibilities.

Gladstone Experts Srivastava Lab

USF Trustee Connects Biotechnology Master’s Students with Exclusive Career Exploration Opportunity

Gladstone in the News September 6, 2024

USF Trustee Connects Biotechnology Master’s Students with Exclusive Career Exploration Opportunity

University of San Francisco—Students in the Master’s in Biotechnology program at the University of San Francisco visited Gladstone to learn about industry-altering scientific breakthroughs and met with Benoit Bruneany, director of the Gladstone Institute of Cardiovascular Disease, and Stephen Freedman, vice president of corporate liaison and ventures.

Gladstone Experts

Blood Clotting Protein Discovery Upends Conventional COVID-19 Thinking, IDs Potential Therapy

Gladstone in the News August 29, 2024

Blood Clotting Protein Discovery Upends Conventional COVID-19 Thinking, IDs Potential Therapy

Inside Precision Medicine—A new study by Gladstone Senior Investigators Katerina Akassoglou and Warner Greene shows that fibrin, a blood coagulation protein, drives the cascade of symptoms that are the hallmarks of infection by the SARS-CoV-2 virus.

Gladstone Experts COVID-19 Akassoglou Lab

Structure Search Suggests Roles for Thousands of Viral Proteins

Gladstone in the News August 28, 2024

Structure Search Suggests Roles for Thousands of Viral Proteins

Chemical & Engineering News—In a new study, scientists in Jennifer Doudna’s lab probe how viruses interfere with host signaling. Postdoctoral Fellow Jason Nomburg explains how they assembled a database of predicted structures of viral proteins, and used it to find the functions of previously mysterious proteins.

Gladstone Experts Virology Doudna Lab

As Prescribed: Researchers Dive Into the Biology of Autism

Gladstone in the News January 18, 2024

As Prescribed: Researchers Dive Into the Biology of Autism

KCBS Radio—Diagnoses of autism spectrum disorder, or ASD, have been rising over the past decades, with one in 36 children identified with the condition in 2020 compared to one in 150 back in 2000, according to the US Centers for Disease Control and Prevention. Nevan Krogan, PhD, senior investigator at Gladstone Institutes and director of the Quantitative Biosciences Institute at UC San Francisco, shares new research on genetic changes that contribute to ASD.

Gladstone Experts Research (Publication) Neurological Disease Krogan Lab

Could Long COVID’s Signs of Immune Dysregulation in the Blood Lead to a Diagnostic Test?

Gladstone in the News January 18, 2024

Could Long COVID’s Signs of Immune Dysregulation in the Blood Lead to a Diagnostic Test?

STAT—New research has identified proteins present in the blood of people with long COVID that could point the way to a much-needed diagnostic test and possibly to future therapeutic targets. “The dysregulation they observed is a bit complex, as some complement components go up and others go down, but overall the results suggest that complement pathways are abnormal in people with long COVID,” said Gladstone's Nadia Roan, the senior author of a Nature Immunology paper published earlier in January on immune response in long COVID.

Gladstone Experts COVID-19 Roan Lab

‘Striking’ Study Reveals Immune System Anomalies in People with Long COVID

Gladstone in the News January 12, 2024

‘Striking’ Study Reveals Immune System Anomalies in People with Long COVID

San Francisco Chronicle—At least 10 percent of those who survive COVID continue to face debilitating symptoms months after the acute infection resolves. New research from the laboratory of Gladstone Senior Investigator Nadia Roan shows that individuals suffering Long Covid have a dysregulated immune response to the virus and evidence of T cell exhaustion, which may be due to the virus persisting within their bodies.

Gladstone Experts COVID-19 Virology Roan Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media